Skip to main content
Equibles
NEO logo

NEO · Neogenomics Inc

Track NEO — free

Use NEO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NEO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$15.94 -0.45 (-2.75%) At close · Aug 14
Market Cap
$2.14B
Shares
130.21M

Neogenomics Inc Earnings Call Transcripts

Every quarterly earnings call for Neogenomics Inc (NEO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲6.1% $128.78M −$36.85M '22 Q3 22-11-08 ▲10.3% $138.71M −$22.69M '22 Q4 23-02-23 ▲17.1% $137.22M −$30.80M '23 Q1 23-05-08 ▲17.5% $146.92M −$24.33M '23 Q2 23-08-08 ▲18% $151.95M −$18.52M '23 Q3 23-11-06 ▲12.1% $155.55M −$14.33M '23 Q4 24-02-20 ▲13.9% $156.24M −$27.06M '24 Q1 24-04-30 ▲12% $164.50M −$18.64M '24 Q2 24-07-29 ▲10.4% $167.82M −$17.70M '24 Q3 24-11-05 ▲10.6% $172.00M −$15.32M '24 Q4 25-02-18 ▲7.5% $168.03M −$25.92M '25 Q1 25-04-29 ▲10.2% $181.33M −$45.09M '25 Q2 25-07-29 ▲11.9% $187.80M −$27.13M '25 Q3 25-10-28 ▲10.6% $190.17M −$9.88M '25 Q4 26-02-17 LATEST ▲11.1% $186.67M −$17.11M '26 Q1 26-04-28
Earnings call
FY26 · Q2
2026-07-28
Second Quarter 2026 Financial Results Conference Call
Positive tone Clinical revenue and NGS growth Raised full-year guidance Commercial reorganization
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference 2026
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-05-21
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-28
Neogenomics Inc Q1 FY2026 Earnings Call
Confident tone NGS portfolio and PanTracer RaDaR ST MRD launch Pathline acquisition and lab network
Revenue
$186.67M
▲ 11.1% YoY
Gross margin
43.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Leerink Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-03
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-17
Neogenomics Inc Q4 FY2025 Earnings Call
Revenue
$190.17M*
▲ 10.6% YoY
Gross margin
43.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-01-13
44th Annual J.P. Morgan Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-10-28
Neogenomics Inc Q3 FY2025 Earnings Call
Revenue
$187.80M
▲ 11.9% YoY
Gross margin
42.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Neogenomics Inc Q2 FY2025 Earnings Call
Revenue
$181.33M
▲ 10.2% YoY
Gross margin
42.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Neogenomics Inc Q1 FY2025 Earnings Call
Revenue
$168.03M
▲ 7.5% YoY
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Neogenomics Inc Q4 FY2024 Earnings Call
Revenue
$172.00M*
▲ 10.6% YoY
Gross margin
44.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Neogenomics Inc Q3 FY2024 Earnings Call
Positive tone NGS as Growth Driver New Product Launches Pharma / Clinical Services Turnaround
Revenue
$167.82M
▲ 10.4% YoY
Gross margin
44.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
Neogenomics Inc Q2 FY2024 Earnings Call
Revenue
$164.50M
▲ 12% YoY
Gross margin
44.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Neogenomics Inc Q1 FY2024 Earnings Call
Revenue
$156.24M
▲ 13.9% YoY
Gross margin
41.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Neogenomics Inc Q4 FY2023 Earnings Call
Revenue
$155.55M*
▲ 12.1% YoY
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Neogenomics Inc Q3 FY2023 Earnings Call
Revenue
$151.95M
▲ 18% YoY
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Neogenomics Inc Q2 FY2023 Earnings Call
Revenue
$146.92M
▲ 17.5% YoY
Gross margin
40.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Neogenomics Inc Q1 FY2023 Earnings Call
Revenue
$137.22M
▲ 17.1% YoY
Gross margin
39.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Neogenomics Inc Q4 FY2022 Earnings Call
Revenue
$138.71M*
▲ 10.3% YoY
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Neogenomics Inc Q3 FY2022 Earnings Call
Revenue
$128.78M
▲ 6.1% YoY
Gross margin
38.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Neogenomics Inc Q2 FY2022 Earnings Call
Revenue
$125.07M
▲ 2.8% YoY
Gross margin
35.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Neogenomics Inc Q1 FY2022 Earnings Call
Revenue
$117.17M
▲ 1.4% YoY
Gross margin
32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Neogenomics Inc Q4 FY2021 Earnings Call
Revenue
$125.73M*
▼ 0.2% YoY
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Neogenomics Inc Q3 FY2021 Earnings Call
Revenue
$121.34M
▼ 3.3% YoY
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Neogenomics Inc Q2 FY2021 Earnings Call
Revenue
$121.72M
▲ 39.9% YoY
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Neogenomics Inc Q1 FY2021 Earnings Call
Revenue
$115.53M
▲ 9% YoY
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Neogenomics Inc Q4 FY2020 Earnings Call
Revenue
$126.00M*
▲ 17.9% YoY
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Neogenomics Inc Q3 FY2020 Earnings Call
Revenue
$125.44M
▲ 19.8% YoY
Gross margin
43.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Neogenomics Inc Q2 FY2020 Earnings Call
Revenue
$86.98M
▼ 14.5% YoY
Gross margin
32.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-09
Neogenomics Inc Q1 FY2020 Earnings Call
Revenue
$106.03M
▲ 10.9% YoY
Gross margin
43.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Neogenomics Inc Q4 FY2019 Earnings Call
Revenue
$106.87M
▲ 39.7% YoY
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–32 of 32 earnings calls
Key facts CIK 1077183 CUSIP 64049M209 13F (30d) 250 filings 248 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)